In Vitro Diagnostics Technology and Industry Development Summit-2011

Venue: Shanghai Everbright Convention & Exhibition Center

Location: Shanghai, China

Event Date/Time: Jun 18, 2011 End Date/Time: Jun 20, 2011
Registration Date: Jun 10, 2011
Early Registration Date: Nov 30, 2010
Abstract Submission Date: May 10, 2011
Paper Submission Date: May 20, 2011
Report as Spam


In Vitro Diagnostics Technology and Industry Development Summit
June 18-20, 2011
Shanghai Everbright Convention & Exhibition Center, China
The In Vitro Diagnostics Technology and Industry Development Summit will take place June 18 through 20, 2011 at Shanghai Everbright Convention & Exhibition Center, China.

Identify the key trends and developments that are driving the In Vitro Diagnostics market in China and globally;
Learn about the latest technical developments of pharma and diagnostics through presentations and panel discussions;
Analyze the most viable In Vitro diagnostics sectors to successfully align your future strategies;
Examine regulatory challenges and how they can be overcome.
Further details for scientific sessions are outlined at Agenda.

Attendees include: Clinicians, Laboratory Developers, Chief Executives, Vice Presidents, Directors, Chief Scientists, Project Leaders of Molecular Genetics, Molecular Medicine, Molecular Diagnostics and other related areas who develop, provide, and perform IVD solutions.

Organized by eChinaChem, Inc., Shanghai Licensed Pharmacist Association, The Shanghai Medical Instrument Trade Association, Research Center of Econometrics, Shanghai Academy of Social Sciences, In Vitro Diagnostics Technology and Industry Development Summit every year since 2011. For more information about the organizers, please refer to Organizers.

IVD development is at the frontier of medical services and research, and is a key area in preventive medicine R&D. Innovations and advancement in various IVD technologies have led to the development of new diagnostics test applications, resulting in a phenomenal growth of the IVD market. The IVD market of China, averaging double-digit growth annually in the past decade, has fostered competition amongst IVD firms in recent years, thus accelerating development of new technologies and products.

The global IVD market totaled $34 billion in 2007 and $38 billion for 2008. Despite the 2009 global economic crisis, the conditions of the traditional IVD market has not changed and it is expected to generate an annualized 9% growth rate from 2010 to 2012 according to market analysts.

At present, China is still one of the lowest IVD consumption per capita countries, with about 1/5 of the population of the world and only 2% of the global IVD industry market share. Yet China is the fastest growing market, with an average annual growth rate of 15%.

The 2009 outbreak of Influenza A (H1N1) has stimulated the IVD industry. Many pharmaceutical companies utilized IVD detection kits for influenza virus research and development investment, and benefited from related IVD R&D efforts.

This Summit will discuss commercial and regulatory challenges in China, the recent development of diagnostic reagents in the biopharmaceutical industry, emerging technologies in diagnostics and other development for IVD, and will offer an opportunity for persons interested in every aspect of IVD to become familiar with cutting-edge developments and their potential application in IVD arenas.


66 Caobao Road, Xuhui district, Shanghai, China

Additional Information

Sessions during the conference will include Session 1: In Vitro Diagnostics: Commercial and Regulatory Challenges in China Session 2: Recent Development of Diagnostic Reagents in Biopharmaceutical Industry Session 3: Clinical Applications of Molecular Diagnostics Session 4: Molecular Diagnostics and Personalized Medicine Session 5: Emerging Technologies in Diagnostics Session 6: High-throughput,Rapid and Low cost Detection Technologies Session 7: Biomarkers in Diagnostics Session 8: Proteomics, Pharmacogenomics and Companion Diagnostics Session 9: Point-of-Care Diagnostic Systems Session 10: Biochips and Biosensors based Molecular Diagnostics Session 11: Total solution of Molecular Diagnostics: From sample to results Session 12: Diagnostic Reagents: From Bench to Bedside Session 13: Prenatal Diagnosis Session 14: Infectious Disease and Rapid Detection Session 15: Cancer Prevention and Early Detection Session 16: Diagnostic Reagents for Genetic Disease Session 17: Cardiovascular Diagnostics Session 18: Diabetes and Other Metabolic Disease